Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells

Fig. 1

Dose-response curves of DDP, TET and the combination treatment. Cisplatin-resistant (a) and cisplatin-sensitive (b) A549 cells were treated with different concentrations of the two drugs (TET: 0.5–8 µg/ml; DDP: 6.25–100 µM) for 48 h. The concentration of TET in the combination treatment was 0.25 µg/ml. C and D are the IC50 values of DDP and combination treatment. *p < 0.05 versus the DDP treatment (n = 3)

Back to article page